Vaccines
Vacc-4x shows reduction in viral load, decision to halt development reversed
After further analyses of the international, randomized, double-blind, placebo-controlled multi-center phase IIb study of Bionor Pharma's therapeutic HIV-vaccine candidate, Vacc-4x, the Company reports an...